Inter-Observer Agreement in Assessment of Response to Neo-Adjuvant Chemotherapy in Tubo-Ovarian High-Grade Serous Carcinoma

被引：0
|
作者：
Singh, Naveena
Said, Ian
Faruqi, Asma Z.
Leen, Sarah L.
Trevisan, Giorgia
Hirschowitz, Lynn
Ganesan, Raji
Vella, Jo
McCluggage, Glenn
Gilks, Blake
Boehm, Steffen
机构：
[1] Barts Hlth NHS Trust, London, England
[2] Univ Coll London Hosp, London, England
[3] Birmingham Womens Hosp, Birmingham, W Midlands, England
[4] Royal Victoria Hosp, Belfast BT12 6BA, Antrim, North Ireland
[5] Vancouver Gen Hosp, Vancouver, BC, Canada
来源：
LABORATORY INVESTIGATION | 2016年 / 96卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1229
引用
收藏
页码：309A / 310A
页数：2
相关论文
共 50 条
  • [31] TP53-wildtype High-Grade Serous Tubo-Ovarian Carcinomas
    Chui, M. Herman
    Soslow, Robert
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1029 - 1029
  • [32] Ovarian carcinosarcoma is a distinct form of ovarian cancer with poorer survival compared to tubo-ovarian high-grade serous carcinoma
    Hollis, Robert L.
    Croy, Ian
    Churchman, Michael
    Bartos, Clare
    Rye, Tzyvia
    Gourley, Charlie
    Herrington, C. Simon
    BRITISH JOURNAL OF CANCER, 2022, 127 (06) : 1034 - 1042
  • [33] Ovarian carcinosarcoma is a distinct form of ovarian cancer with poorer survival compared to tubo-ovarian high-grade serous carcinoma
    Robert L. Hollis
    Ian Croy
    Michael Churchman
    Clare Bartos
    Tzyvia Rye
    Charlie Gourley
    C. Simon Herrington
    British Journal of Cancer, 2022, 127 : 1034 - 1042
  • [34] Tubo-Ovarian Transitional Cell Carcinoma and High-grade Serous Carcinoma Show Subtly Different Immunohistochemistry Profiles
    Magrill, Jamie
    Karnezis, Anthony N.
    Tessier-Cloutier, Basile
    Talhouk, Aline
    Kommoss, Stefan
    Cochrane, Dawn
    Chow, Christine
    Cheng, Angela
    Soslow, Robert
    Hauptmann, Steffen
    du Bois, Andreas
    Pfisterer, Jacobus
    Gilks, C. Blake
    Huntsman, David G.
    Kommoss, Friedrich
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2019, 38 (06) : 552 - 561
  • [35] Proteomic analysis of transitional cell carcinoma-like variant of tubo-ovarian high-grade serous carcinoma
    Tessier-Cloutier, Basile
    Cochrane, Dawn R.
    Karnezis, Anthony N.
    Colborne, Shane
    Magrill, Jamie
    Talhouk, Aline
    Zhang, Jonathan
    Leung, Samuel
    Hughes, Christopher S.
    Piskorz, Anna
    Cheng, Angela S.
    Greening, Kendall
    du Bois, Andreas
    Pfisterer, Jacobus
    Soslow, Robert A.
    Kommoss, Stefan
    Brenton, James D.
    Morin, Gregg B.
    Gilks, C. Blake
    Huntsman, David G.
    Kommoss, Friedrich
    HUMAN PATHOLOGY, 2020, 101 : 40 - 52
  • [36] Intralymphatic Histiocytosis Associated With Tubo-ovarian High-grade Serous Carcinoma: Case Report and Review of the Literature
    Bonometti, Arturo
    Carbone, Riccardo
    Cassani, Chiara
    Dioli, Claudia
    Lucato, Elena
    Spinillo, Arsenio
    Paulli, Marco
    Cesari, Stefania
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2023, 42 (02) : 192 - 195
  • [37] Prognostic value of progesterone receptor expression in tubo-ovarian high-grade serous carcinoma of the COEUR cohort
    Le Page, Cecile
    Rahimi, Kurosh
    Mes-Masson, Anne-Marie
    Kobel, Martin
    HISTOPATHOLOGY, 2019, 74 (04) : 663 - 666
  • [38] Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma
    Wang, Chen
    Block, Matthew S.
    Cunningham, Julie M.
    Sherman, Mark E.
    McCauley, Bryan M.
    Armasu, Sebastian M.
    Vierkant, Robert A.
    Traficante, Nadia
    Talhouk, Aline
    Doherty, Jennifer A.
    Pejovic, Nadja
    Kobel, Martin
    Jorgensen, Brooke D.
    Garsed, Dale W.
    Fereday, Sian
    Ramus, Susan J.
    Ariyaratne, Dinuka
    Anglesio, Michael S.
    Widschwendter, Martin
    Pejovic, Tanja
    Bosquet, Jesus Gonzalez
    Bowtell, David D.
    Winham, Stacey J.
    Goode, Ellen L.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2023, 32 (03) : 542 - 549
  • [39] Rare case of paraneoplastic cerebellar degeneration secondary to high-grade serous carcinoma of tubo-ovarian origin
    Butt, Eman
    Tadross, John A.
    Chadda, Karan R.
    Latimer, John
    BMJ CASE REPORTS, 2019, 12 (08)
  • [40] Clinical and molecular predictors of outcome in patients with tubo-ovarian high-grade serous carcinoma and exceptional survival
    Zwimpfer, T. A.
    Pandey, A.
    Fereday, S.
    Coelho, R. J. B-N.
    Twomey, L.
    Ariyaratne, D.
    Traficante, N.
    Jacob, F.
    Eller, R.
    Heinzelmann-Schwarz, V.
    Christie, E. L.
    Kennedy, C.
    Au-Yeung, G.
    Ramus, S.
    Koebel, M.
    Nelson, B.
    Goode, E. L.
    DeFazio, A.
    Bowtell, D. D. L.
    Garsed, D. W.
    ANNALS OF ONCOLOGY, 2024, 35 : S571 - S571
12345